/BZYR
BZYR Stock - Burzynski Research Institute, Inc.
Healthcare|BiotechnologyOTC
$0.04+0.00%
+$0.00 (+0.00%) • Dec 19
61
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.26
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.04
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for BZYR
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.04 – $0.04
TARGET (TP)$0.04
STOP LOSS$0.03
RISK/REWARD1:0.4
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.16
52W High$0.06
52W Low$0.03
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-1,386,207 | $-1,335,431 | $-916,292 | $-976,656 | $-1,301,771 |
| Net Income | $-1,386,207 | $-1,335,431 | $-916,292 | $-976,656 | $-1,203,998 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.01 |
Company Overview
Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs to treat cancer. The company is also involved in the production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. Burzynski Research Institute, Inc. was founded in 1977 and is based in Houston, Texas.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
BZYRBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q4 2025
EPS Surprise History
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 18, 2026 | — | — | — | — |
Q1 2026 | Jan 12, 2026 | — | — | — | — |
Q4 2025 | Oct 8, 2025 | — | $-0.00 | — | — |
Q3 2025 | Jul 14, 2025 | — | $-0.00 | — | — |
Q2 2025 | May 20, 2025 | — | $-0.00 | — | — |
Q1 2025 | Jan 14, 2025 | — | $-0.00 | — | — |
Q4 2024 | Oct 10, 2024 | — | $-0.00 | — | — |
Q3 2024 | Jul 15, 2024 | — | $-0.00 | — | — |
Q2 2024 | May 29, 2024 | — | $-0.00 | — | — |
Q1 2024 | Jan 16, 2024 | — | $-0.00 | — | — |
Q4 2023 | Oct 12, 2023 | — | $-0.00 | — | — |
Q3 2023 | Jul 13, 2023 | — | $-0.00 | — | — |
Q2 2023 | May 25, 2023 | — | $-0.00 | — | — |
Q1 2023 | Jan 13, 2023 | — | $-0.00 | — | — |
Q4 2022 | Oct 13, 2022 | — | $-0.00 | — | — |
Q3 2022 | Jul 14, 2022 | — | $-0.00 | — | — |
Q2 2022 | May 26, 2022 | — | $-0.00 | — | — |
Q1 2022 | Jan 14, 2022 | — | $-0.00 | — | — |
Q4 2021 | Oct 15, 2021 | — | $-0.00 | — | — |
Q3 2021 | Jul 15, 2021 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about BZYR
What is BZYR's current stock price?
Burzynski Research Institute, Inc. (BZYR) is currently trading at $0.04 per share. The stock has moved +0.00% today.
What is the analyst price target for BZYR?
No analyst price targets are currently available for this stock.
What sector is Burzynski Research Institute, Inc. in?
Burzynski Research Institute, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.
What is BZYR's market cap?
Burzynski Research Institute, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does BZYR pay dividends?
No, Burzynski Research Institute, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBETRF
BetterLife Pharma Inc.
$0.04
Mkt Cap: $0.0B
BIXT
Bioxytran, Inc.
$0.07
Mkt Cap: $0.0B
BVAXF
BioVaxys Technology Corp.
$0.18
Mkt Cap: $0.0B
CPMV
Mosaic ImmunoEngineering Inc.
$0.50
Mkt Cap: $0.0B
FAMDF
Futura Medical plc
$0.02
Mkt Cap: $0.0B
GLWLF
Glow Lifetech Corp.
$0.04
Mkt Cap: $0.0B
KNBIF
Kane Biotech Inc.
$0.03
Mkt Cap: $0.0B
MYNDF
MYND Life Sciences Inc.
$0.01
Mkt Cap: $0.0B
THER
Theralink Technologies, Inc.
$0.00
Mkt Cap: $0.0B
TXTM
ProText Mobility, Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to BZYR for comparison